Patrick Frost, PhD

Patrick Frost, PhD

Jan 23, 2016

Group 6 Copy 47
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

How does the struggle between sexual selection and natural selection drive the coloration of a tropical gecko?

On animal coloration, sexual selection may promote conspicuousness while natural selection may favor crypsis...

Organofoam: Can we improve biodegradable fungal styrofoam substitutes?

Petroleum-based materials such as Styrofoam, while convenient, seriously threaten our environment, releasing...

Probiotics for plants? Fighting insects by boosting corn immune systems

Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

Backer Badge Funded